Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) jumped 28% in the morning session after the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.
Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
AdaptHealth’s shares are very volatile and have had 23 moves greater than 5% over the last year. But moves this big are rare even for AdaptHealth and indicate this news significantly impacted the market’s perception of the business.
AdaptHealth is up 10.4% since the beginning of the year, and at $10.70 per share, it is trading close to its 52-week high of $11.60 from June 2024. Investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at an investment worth $672.42.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。